4 trends tracked about this subject — the full history, oldest to newest below.
Novo Nordisk has launched a lawsuit against Eli Lilly, challenging the advertising claims made by the competitor regarding their weight-loss medications.
Novo Nordisk has launched legal action against Eli Lilly, alleging that its rival engaged in deceptive marketing practices regarding weight-loss medications.
Novo Nordisk has entered a partnership with Vivani to develop a long-acting semaglutide implant designed for extended weight loss management.
AI-driven biotech acquisition accelerates Parkinson’s stem cell therapy into clinical trials